<DOC>
	<DOCNO>NCT00869011</DOCNO>
	<brief_summary>In randomize , control trial investigator evaluate effect exercise program lasting 12 week physical performance , cardiovascular function ( 24h blood pressure , rest blood pressure hear function ) fatigue mood patient renal cell carcinoma undergo therapy Sunitinib .</brief_summary>
	<brief_title>Exercise Patients With Renal Cell Cancer Receiving Sunitinib</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>18 75 year Understanding write German Treatment Sunitinib Ability walk Cardiovascular , pulmonary osteoarticular disease aggravate exercise BMI &lt; 18 &gt; 30</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Cancer</keyword>
	<keyword>renal cell carcinoma</keyword>
	<keyword>fatigue</keyword>
	<keyword>exercise</keyword>
</DOC>